You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨自研創新產品走向全球,貝康醫療半日收升18.53%
格隆匯 07-14 12:10
格隆匯7月14日丨貝康醫療-B(2170.HK)今日表現活躍,盤中一度升20.08%至3.11港元,截至半日收盤升18.53%報3.07港元。消息面上,7月4日,貝康醫療與全球頂尖的生育集團Genea集團簽署戰略合作協議。Genea集團業務涵蓋輔助生殖臨牀醫療、輔助生殖科技以及醫療設備及耗材。Genea集團還是全球十大試管嬰兒成功率最高的輔助生殖醫療集團,在全球擁有15家生殖機構。貝康醫療將向Genea集團旗下醫療機構提供覆蓋全生育週期的檢測試劑盒、高通量基因測序儀、男科精液檢測分析產品、液氮儲存系統等儀器設備、耗材和試劑盒。同時,Genea集團將在貝康醫療的產品開發中提供協助,包括海外臨牀驗證以及監管批准中的一系列支持。此次戰略合作將助力貝康醫療提升覆蓋輔助生殖行業的能力,並通過Genea集團的醫療資源和廣闊的全球銷售網絡,推動貝康醫療自研創新產品走向全球。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account